Condition: Cutaneous Melanocytic Neoplasm · Large Cutaneous Melanocytic Nevi · Neurocutaneous Melanocytosis · Sponsor: Memorial Sloan Kettering Cancer Center
This study will involve collecting information about the regular medical care you receive for large cutaneous melanocytic nevi (LCMN) or neurocutaneous melanocytosis (NCM).
This description comes directly from the study's public registry record.
Yasmin Khakoo, MD · 212-639-8292 · khakooy@mskcc.org
Sofia Haque, MD · 212-639-7170 · haques@MSKCC.ORG
Always discuss trial participation with your own doctor first.
| Boston Children's Hospital (Data Analysis Only) | Boston, Massachusetts, United States | Not Yet Recruiting |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04548817